Bioventus (BVS) Depreciation & Amortization (CF) (2020 - 2026)

Bioventus (BVS) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $11.2 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 5.56% year-over-year to $11.2 million; the trailing twelve-month figure through Mar 2026 stood at $46.4 million (down 6.62% YoY), and the FY2025 full-year result was $47.0 million, down 5.13% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $11.2 million, down from $11.7 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $16.9 million in Q4 2022 and bottomed at $11.2 million in Q1 2026.
• The 5-year median for Depreciation & Amortization (CF) is $12.4 million (2024), against an average of $13.0 million.
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) soared 73.71%; it then retreated 28.46% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $16.9 million in 2022, then declined by 26.43% to $12.5 million in 2023, then slipped by 0.48% to $12.4 million in 2024, then slipped by 5.73% to $11.7 million in 2025, then slipped by 4.18% to $11.2 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $11.2 million (Q1 2026), $11.7 million (Q4 2025), and $11.4 million (Q3 2025), per Business Quant data.

Peer Comparison